Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Enhanced radiosensitivity of pancreatic cancer achieved through inhibition of Cyclin-dependent kinase 1

Radiotherapy and Oncology(2024)10.1016/j.radonc.2024.110531Source: DataRank Database

Enhanced radiosensitivity of pancreatic cancer achieved through inhibition of Cyclin-dependent kinase 1 is a research paper published in Radiotherapy and Oncology (2024). On theSindex it has a DataRank of 0. It has been cited 6 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

6 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 1.04)OA: closedTopics (31)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Saaimatul Huq,Lokesh Akana ORCID,Daniel E. Eldridge ORCID,Óscar Zúñiga ORCID,Henrique Rodrigues ORCID

Live enrichment

PubMed:39270987 OpenAlex:https://openalex.org/W4402439744

American Society for Radiation Oncology

Grant: CSDG-23-1037280-01

American Cancer Society

Grant: ASTRO-CSDG-23-1037280-01-CDP

National Institutes of Health

Grant: KL2 TR003108

National Institute of General Medical Sciences

Grant: R24GM137786

National Center for Advancing Translational Sciences

FWCI

1.04

Citation Percentile

0.8%

Citation Trend

2025

2026

closedLicense: https://doi.org/10.15223/policy-004

publisherhttps://api.elsevier.com/content/article/PII:S0167814024035096?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0167814024035096?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.radonc.2024.110531

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39270987

Fields of Study

Cancer-related Molecular PathwaysPancreatic and Hepatic Oncology ResearchMicrotubule and mitosis dynamics

MeSH Terms

AnimalsHumansPancreatic NeoplasmsQuinolinesRadiation ToleranceThiazolesCDC2 Protein KinaseCarcinoma, Pancreatic DuctalCell Line, TumorMice

Keywords

RadioresistanceRadiosensitivityCancer researchPancreatic cancerCyclin-dependent kinase 1KinaseMedicineAdenocarcinomaOncologyCancerInternal medicineBiologyCell cycleRadiation therapyCell biologyradiation resistanceCdk1Translational

Sustainable Development Goals

SDG 0: Good health and well-being

Enhanced radiosensitivity of pancreatic cancer achieved through inhibition of Cyclin-dependent kinase 1

FAIR Checklist

Authors (7)

Funding (5 grants)

Impact

Open Access

Topics